Javascript must be enabled to continue!
Neuropharmacology of Tranylcypromine and Trifluoperazine
View through CrossRef
Tranylcypromine was compared to trifluoperazine in a number of pharmacological test procedures. Both compounds were effective in producing catalepsy, a selective blockade of the conditioned stimulus, and potentiation of hexobarbital-induced sleep. Unlike trifluoperazine, tranylcypromine was very effective as a tryptamine potentiator, a reflection of its activity as an in vivo inhibitor of the enzyme monoamine oxidase. Tranylcypromine was ineffective in producing any appreciable decrease in spontaneous motor activity at doses up to 20 mg/kg, whereas the DD50for trifluoperazine was 1.1 mg/kg.
Title: Neuropharmacology of Tranylcypromine and Trifluoperazine
Description:
Tranylcypromine was compared to trifluoperazine in a number of pharmacological test procedures.
Both compounds were effective in producing catalepsy, a selective blockade of the conditioned stimulus, and potentiation of hexobarbital-induced sleep.
Unlike trifluoperazine, tranylcypromine was very effective as a tryptamine potentiator, a reflection of its activity as an in vivo inhibitor of the enzyme monoamine oxidase.
Tranylcypromine was ineffective in producing any appreciable decrease in spontaneous motor activity at doses up to 20 mg/kg, whereas the DD50for trifluoperazine was 1.
1 mg/kg.
Related Results
Trifluoperazine causes mast cell apoptosis through a secretory granule-mediated pathway
Trifluoperazine causes mast cell apoptosis through a secretory granule-mediated pathway
Abstract
Mast cells contribute to the pathology of various diseases, in particular allergic conditions. Therefore, it is essential to develop strategies that effi...
Combination of Tranylcypromine and Mirtazapine in Difficult-to-Treat Depression
Combination of Tranylcypromine and Mirtazapine in Difficult-to-Treat Depression
Abstract
Background
About one third of depression patients do not respond to the first antidepressant trial. Difficult-to-treat depression was su...
Effects of trifluoperazine and mitogenic lectins on calcium ATPase activity and calcium transport by human lymphocyte plasma membrane vesicles
Effects of trifluoperazine and mitogenic lectins on calcium ATPase activity and calcium transport by human lymphocyte plasma membrane vesicles
AbstractThe phenothiazine, trifluoperazine, and the mitogenic lectins, phytohemagglutinin (PHA) and Concanavalin A (Con A), were tested for their effects on human lymphocyte plasma...
Safety of concomitant tranylcypromine treatment during electroconvulsive therapy (ECT) series
Safety of concomitant tranylcypromine treatment during electroconvulsive therapy (ECT) series
IntroductionTranylcypromine (TCP), an irreversible monoamine oxidase inhibitor (MAOI), is recommended for difficult-to-treat depression. Besides the requirement of a low-tyramine d...
Comparing effectiveness of risperidone with first-generation antipsychotic medications in patients with schizophrenia-spectrum disorders
Comparing effectiveness of risperidone with first-generation antipsychotic medications in patients with schizophrenia-spectrum disorders
This naturalistic retrospective study aims to compare effectiveness of a second-generation antipsychotic medication, risperidone, with first-generation antipsychotic medications (h...
Trifluoperazine induced blepharospasm: a case report
Trifluoperazine induced blepharospasm: a case report
We hereby report an unusual case of trifluoperazine (typical antipsychotic drug) induced tardive blephrospasm which was relieved subsequently after dechallenging the drug. Thereaft...
The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in SEC62 overexpressing tumors
The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in SEC62 overexpressing tumors
The human SEC62 gene is located on chromosome 3q, was characterized as a tumor driver gene and is found to be overexpressed in an ever-growing number of tumors, particularly those ...
Synergistic Effects of Tranylcypromine and NRF2 Inhibitor: A Repurposing Strategy for Effective Cancer Therapy
Synergistic Effects of Tranylcypromine and NRF2 Inhibitor: A Repurposing Strategy for Effective Cancer Therapy
AbstractDrug repurposing has emerged as an attractive strategy for accelerating drug discovery for cancer treatment. In this study, we investigated combining Tranylcypromine (TCP) ...

